About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C

NCT00399815·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Yves J Horsmans, M.D., Ph.D.
CONTACT
32 2 764 28 37 horsmans@gaen.ucl.ac.be
Bernard VanBeers, M.D.,
CONTACT
32 2 764 29 45 vanbeers@rdgn.ucl.ac.be

Lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

alteration of liver function tests (ALT, AST)
HCV RNA positive

You may not be if

clotting disorder
ongoing treatment with anti-coagulant or anti-aggregant
advanced or decompensated cirrhosis (Child-Pugh class C)
hepatocellular carcinoma
other cancer
history of surgery for brain aneurysm
pace maker or defibrillator
ocular metal foreign body

The record

StatusUnknown

PhaseNo phase

Taking part40

StartedJun 2006

UpdatedSep 18, 2009

Conditions

Hepatitis C, Chronic

Where1

Cliniques Universitaires StLuc, Université catholique de Louvain (UCL)
Brussels, Belgium